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In contrast to procarboxypeptidase B which has always been reported to be secreted by the pancreas as a monomer, procarboxypeptidase A occurs 
as a monomer and/or associated to one or two functionally different proteins, depending on the species. Recent studies showed that, in the human 
pancreatic secretion, procarboxypeptidase A is mainly secreted as a 44 kDa protein involved in at least three different binary complexes. As previous- 
ly reported, two of these complexes associated procarboxypeptidase A to either a glycosylated truncated protease E or zymogen E. In this paper, 
we identified proelastase 2as the partner of procarboxypeptidase A in the third complex, thus reporting for the first time the occurrence of a proelas- 
tase 2/procarboxypeptidase A binary complex in vertebrates. Moreover, from N-terminal sequence analyses, the 44 kDa procarboxypeptidase A 
involved in these complexes was identified as being of the A, type. Only one type of procarboxypeptidase B, the B, type, has been detected in 
the analyzed pancreatic juices, thus emphasizing the previously observed genetic differences between individuals. 
Human pancreas; Procarboxypeptidase; Protease E; Proelastase 2; Protein complex 
1. INTRODUCTION 
Various molecular forms of secreted proCPA, 
resulting from its ability to bind to other pancreatic 
serine endopeptidases, have been reported. In some 
ruminant species, proCPA is secreted as a ternary com- 
plex [ 1,2] in association with a chymotrypsinogen of the 
C-type [3] and a truncated protease E [4,5]. Binary 
complexes in which proCPA is associated to either 
probably a chymotrypsinogen of the C-type or to 
zymogen E have been described in the sei whale [6] and 
in the pig [7], respectively. In the human secretion, two 
major binary complexes in which proCPA is associated 
to either a glycosylated truncated protease E (32 kDa) 
or an unidentified 28 kDa protein have been reported 
[8]. A binary form in which proCPA is bound to 
zymogen E has also been described in human pancreas 
[9]. On the other hand, in several species such as dog 
[lo], dogfish [ll], lungfish [12] and horse [2], proCPA 
is secreted as a monomer. However, in some species, 
proCPA is secreted in two states. Thus, besides the 
above-mentioned binary forms, the porcine [7] and 
human [9] secretions contain monomeric proCPA. 
Besides this heterogeneity of molecular forms of 
secretion, two types of proCPA (Ai and AZ), differing 
by their substrate specificities and primary sequences 
and resulting from gene duplication, allelic polymor- 
phism and/or differential processing of the mature en- 
zyme have been reported in man [13] and rat [14]. Two 
types of proCPB (Bi and Bz) have also been reported in 
man [13]. 
In this paper, we report that in the human pancreatic 
juices investigated, the 28 kDa protein associated to 
proCPA is a proelastase 2. Moreover, from N-terminal 
sequence analyses, the human 44 kDa proCPA of the 
two binary complexes was shown to belong to the Ai 
type and the proCPB to the Bi type. 
2. MATERIALS AND METHODS 
2.1. Materials 
Correspondence address: C. Chapus, Centre de Biochimie et de 
Biologie Moleculaire du CNRS, 31 Chemin Joseph Aiguier, 13402 
Marseille Cedex 9, France 
Abbreviations: DMMA, 2,3 dimethylmaleic anhydride; t-Boc Ala N- 
t-Boc-L-alaninep-nitrophenyl ester; HPLA, hippuryl-L- phenyllactic 
acid and HA, hippuryl-L-arginine; ProCPA, procarboxypeptidase A; 
proCPB, procarboxypeptidase B; CPA, carboxypeptidase A; CPB, 
carboxypeptidase B 
Lyophilized pancreatic juices devoid of any proteolytic activity 
were a generous gift from Dr Lombard0 (CBBM, CNRS, Marseille). 
DMMA and t-Boc Ala ONp were purchased from Sigma (St Louis, 
MO, USA). HPLA and HA were from Bachem (Budendorf, 
Switzerland). Benzamidine was from Fluka (Zurich, Switzerland). All 
chemicals used in this study were of analytical grade and were used 
without further purification. Ultrogel AcA 54 and DE-Trisacryl were 
from IBF (Villeneuve-la-Garenne, France) and Superose 12 from 
Pharmacia (Uppsala, Sweden). 
2.2. Methods 
Enzymes: (pro)carboxypeptidase A (EC 3.4.17.1); (pro)carboxypep- 
tidase B (EC 3.4.17.2); pro(elastase), (zymogen E) protease E (EC 
3.4.21.36); trypsin (EC 3.4.21.4) 
2.2.1. Filtration of lyophylized human pancreatic juice on AcA 54 
Ultrogel 
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This filtration was performed as reported in [S]. 
2.2.2. Activity measurements 
CPA activity was potentiometrically measured after tryptic activa- 
tion as previously reported [15] using a 1 mM HPLA solution as 
substrate. In order to avoid the inhibitory effect of the activation pep- 
tide, monomeric proCPA was first acylated by DMMA before tryptic 
activation 1151. The CPB activity was determined spec- 
trophotometrically after tryptic activation using a 1 mM HA solution 
according to [16]. The protease E and elastase 2 activities were deter- 
mined potentiometrically at pH 7.5 and 25°C using a 10 mM N-acetyl 
L-tyrosine ethyl ester solution as substrate in a 1 mM Tris-HCl buffer 
containing 0.1 M NaCl. Spectrophotometric assays for protease E 
and elastase 2activities were also performed at pH 6.0 and 25°C using 
0.8 mM t-Boc Ala ONp as substrate according to [17]. 
2.2.3. Purification and dissociation of the binary complexes 
The fractions containing the binary complexes eluted from the 
above-mentioned gel filtration column were purified as reported [S]. 
The dissociation of the two binary complexes was performed by treat- 
ment with DMMA as previously reported [18]. The free 
dimethylmaleylated subunits of the complexes were then separated by 
molecular sieving on an AcA Ultrogel54 Ultrogel(1 cm x 4 m) or on 
a Superose 12 column using a Fast Protein Liquid Chromatograph 
(Pharmacia). The columns were equilibrated and eluted with a 0.1 M 
sodium bicarbonate buffer, pH 9.0, containing 0.4 M NaCl and 1 mM 
benzamidine. Deacylation of the subunits was obtained by dialysis at 
4°C for 48 h at pH 7.0 for proCPA and for 24 h at pH 6.0 for the 
other two proteins. 
2.2.4. Purification of monomeric procarboxypeptidase B 
The fractions containing proCPB resulting from AcA 54 gel filtra- 
tion of lyophilized human pancreatic juice were pooled, extensively 
dialyzed against a 20 mM Tris-HCl buffer, pH 8.0, containing 50 mM 
NaCl and 1 mM benzamidine, and then chromatographed on a DE- 
Trisacryl column (2 x 15 cm) equilibrated in the same buffer. The 
elution was performed using the same buffer. CPA and CPB activities 
were tested as reported above, all along the elution profile. 
2.2.5. Gel electrophoresis 
Electrophoresis in the presence of SDS was carried out in lo-15% 
polyacrylamide gel as described by Laemmli [19] using a Phast gel ap- 
paratus (Pharmacia). The proteins were stained with 0.25% 
Coomassie brilliant blue and destained in acetic acid/ethanol/water 
mixtures (1.5:1.0:17.5, v/v). 
2.2.6. N-terminal sequence analyses 
N-terminal sequence analyses were performed by stepwise Edman 
degradation using a gas phase sequencer (Applied Biosystems, model 
470A). The resulting phenylthiohydantoins were analyzed by HPLC 
using a Ctg column (Brownlee, 5 mm, 2.1 x 220 mm). They were 
eluted by a methanol gradient (lo-46%) in a 5 mM sodium acetate 
buffer, pH 4.84. 
3. RESULTS 
3.1. Purification and characterization of 
binary complexes 
the two 
The two major binary complexes, isolated from gel 
filtration of human pancreatic juice were further 
purified to homogeneity by chromatography on DE- 
Trisacryl as reported [8], and then dissociated using the 
DMMA method elaborated for the dissociation of the 
bovine proCPAS6 ternary complex [ 181. The complete 
separation of the free acylated partners (proCPA, 32 
and 28 kDa proteins) was achieved by molecular sieving 
on AcA 54 Ultrogel or Superose 12 at pH 9.0. For each 
binary complex, two well-separated peaks were obtain- 
ed and the proteins were deacylated as described in sec- 
tion 2. The deacylated protein solutions were found 
homogeneous by SDS gel analysis and investigated 
without further purification. 
As previously reported [8], the 32 kDa protein 
associated to the 44 kDa proCPA in the first complex 
was devoid of any activity towards specific substrates. 
This glycoprotein was unambiguously identified to a 
truncated protease E. 
Table 1 
Comparison of N-terminal sequences of proCPA from various species 
1 5 10 15 20 25 
rat proCPAi [21] NENFVGHQVLRISAADEAQVQKVKELE 
man 44 kDa proCPAa K___D________________________V_____________________________ 
ox proCPA [22] K___D_______________________T_____________E______T____________ 
pig proCPA [23] K___D________________________VD_______________________________ 
rat proCPAz [14] Q___T________Jj________E__I p S H-_&_-I RT L L Q________ 
a44 kDa proCPA from the two human binary complexes (proCPA / truncated 
protease E and proCPA / proelastase 2). The rat proCPA, sequence is used as 
reference 
Table 2 
Comparison of the N-terminal sequences of the CPA from different species 
rat CPA1 [21] 
man CPAa 
ox CPA [7] 
pig CPA [24] 
rat CPA2 1141 
1 5 10 15 20 25 
ALSTDSFNYATYHTLDEIYEFMDLL 
x x x______T_______________________E_______D___L________ 
___K____NT___________-____________________D________--_-_ 
x x T--ST______________ __________ E _____B______ 
EKG GN *____FEA_____ ____ E_______GE______N__ 
aCPA resulting from tryptic activation of proCPA/proelastase 2 binary com- 
plex. The rat CPA is used as reference. Deletions (*) have been inserted in order 
to optimize sequence alignment. x, unidentified residues 
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Fig. 1. DE-Trisacryl chromatography of monomeric procarboxypep- 
tidases. The monomeric procarboxypeptidases were purified on a DE- 
Trisacryl column as indicated in section 2. Flow rate, 35 ml/h; frac- 
tion volume, 3.5 ml. Carboxypeptidase A (----) and B (....-) potential 
activities were determined as described (see section 2) after tryptic ac- 
tivation. 
The isolated 28 kDa protein was found inactive 
towards the various serine endopeptidase substrates. 
However, after incubation with catalytic amounts of 
trypsin, the protein displayed an activity towards both 
N-acetyl L-tyrosine ethyl ester and t-hoc Ala ONp com- 
patible with an elastase 2 specificity. In order to further 
identify this 28 kDa protein, the N-terminal sequence of 
the trypsin activated form has been carried out. The 
following sequence, extending to residue 34, was ob- 
tained: 
1 5 10 15 20 25 30 
XGDPTYPPYVTRVVGGEEARPNSWPWQVSLQYSS 
Except for the first amino acid which has not been 
identified (X), this sequence is identical to that of the 
corresponding sequence of human proelastase 2 deduc- 
ed from cDNA sequencing by Shirasu et al. [20]. This 
finding confirms the activity studies and allows us to 
unambiguously identify the 28 kDa protein to the 
zymogen of human elastase 2. 
3.2. Identification of the proCPA type involved in the 
two binary complexes 
In order to identify the type of the 44 kDa proCPAs 
involved in the two binary complexes, the N-terminal 
sequences of the isolate proCPAs have been determined 
and compared to those of proCPA from various species 
(table 1). These two sequences extending to residue 25, 
were found to be strictly identical and to correspond to 
the A1 type as shown by their higher homology to rat 
proCPA1 than rat proCPA2 [14]. 
Comparisons with proCPAs from other species 
showed that human and porcine proCPAs are very 
homologous (for the first 25 residues a single substitu- 
tion located in position 15 was observed) and also, that 
bovine and porcine proCPAs are likely to be of the Al 
type. 
The N-terminal sequence of the CPA resulting from 
the tryptic activation of the proCPA involved in the 
proelastase 2binary complex, has also been determined 
and compared to those of various CPAs (table 2). This 
sequence although uncompleted, further supports the 
fact that the human 44 kDa proCPA belongs to the Al 
type. 
3.3. Isolation and characterization of monomeric 
procarboxypeptidase B 
ProCPB was eluted from the gel filtration 
chromatography of human pancreatic juice at the elu- 
tion volume expected for a monomeric form [8]. Fur- 
ther purification of the protein by chromotagraphy on 
DE-Trisacryl at pH 8.0 (fig.1) yielded two peaks. 
The first major peak was shown to posses a high 
potential CPB activity and a very low potential CPA ac- 
tivity. Since CPB has been shown to exhibit a low activi- 
ty towards synthetic CPA substrates, it cannot be ascer- 
tained that this peak contains proCPA traces. In the 
minor second peak the percent of proCPA potential ac- 
tivity relative to proCPB significantly increased. The 
CPA activity observed under this peak is likely to come 
from the minor 47 kDa proCPA form, first identified in 
man by Scheele et al. [ 131, since only a 47 kDa band was 
detected by SDS gel electrophoresis. 
The occurrence of monomeric proCPB in the first 
Table 3 
Comparison of N-terminal sequences of proCPB from various species 
man proCPB 
man proCPBr [9] 
man proCPB2 [9] 
rat proCPB [21] 
pig proCPB [23] 
lungfish proCPB [25] 
1 5 10 15 20 25 
HHGGEHFEGEKVFRVNVEDENHINI 
______________________________________________________x_______ 
______________________________________________________~______ 
____ASB_________D___NR_Y ______ S _HG__D-V--_-L 
B S S____________________________H__________________D_Q E 
E P T P R B______N Q D____________ 
The human proCPB sequence is used as reference. x, unidentified residues 
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peak was confirmed by N-terminal sequence analysis. 
The sequence of the first 25 residues of the chain is 
presented in table 3 and compared to those of other 
proCPBs. It appears trictly identical to those of human 
proCPB1 and proCPB2 described by Pascual et al. [9] 
except for residue 22. In contrast to human proCPB2 
which has a glutamine residue in position 22, the 
presence of a histidine residue in this position in the 
monomeric proCPB allows us to postulate that this pro- 
tein is of the Bi type and confirms the occurrence of, at 
least, two forms of the enzyme in man. 
During the N-terminal sequence determination of 
proCPB, another sequence (20 amino acids) very 
similar to that of human CPBr [26] was also detected 
(data not shown). The presence of the contaminant 
(CPBr in the proCPB sample resulted from a non- 
controlled activation of the zymogen. The type of the 
proCPB under the minor peak was not investigated. 
4. DISCUSSION 
In the human pancreatic juices studied, the major 
form of proCPA has a it4, of 44 000 and occurs in two 
binary associations with functionally different proteins. 
One of them has been identified as a glycosylated trun- 
cated protease E [8], and in this paper, we report that 
the second proCPA complex involves proelastase 2. 
This finding is the first evidence for the occurrence of a 
binary complex involving proCPA and proelastase 2. 
Similar amounts of each binary complex were detected, 
suggesting that the truncated protease E and proelastase 
2 compete for the same site on proCPA, with similar af- 
finities. 
The complexes were dissociated using DMMA, which 
induces electrostatic repulsion between the subunits. 
This strongly suggests that the binding of the truncated 
protease E and proelastase 2to proCPA occurs through 
ion pairing as previously observed for the binding of 
truncated protease E to bovine proCPA (181. 
Pascual et al. 191 described, in human pancreas, the 
presence of a single binary complex associating the 44 
kDa proCPA to zymogen E. the immediate precursor 
of protease E. However, it must not be ruled out that 
these discrepancies might result from genetic dif- 
ferences between individu~s. Yet, the presence of a 
glycosylated truncated protease E in human pancreas 
has also been reported by Guy-Crotte et al. [27]. 
The presence of proCPA in association with other 
serine proteases in man and other species raises the 
question of the physiological significance of such com- 
plexes. In vitro, no dissociation has been observed 
during proteolytic activation of the human (data not 
shown) and bovine complexes [15]. Up to now, whether 
or not proteolytic activation induces in vivo the 
dissociation of these complexes remains unknown. It 
can be expected that these associations improve the pro- 
tein digestion by physical effects such as stabilization of 
182 
the proCPA as described for the bovine complex [4]. 
The 44 kDa proCPA in the human binary complexes 
investigated in these studies was shown to belong to the 
Ai type. Seemingly the free or associated 44 kDa pro- 
CPA forms isolated from human pancreas [9] are likely 
to be of the same A1 type. This suggests that although 
different molecular secreted forms of secreted proCPA 
have been reported, human proCPA mainly occurs as a 
single 44 kDa form belonging to the Ar type. 
ProCPB was found secreted as a monomer with a M, 
of 47 000. From N-terminal sequence analysis, the ma- 
jor form of proCPB can be classified into the B1 type 
since it contains an histidine residue in position 22. 
Pascual et al. [9] reported a glutamine residue in the 
same position in human proCPB2. Except for this 
residue, the sequences of the first 25 amino acids of the 
Bi and B2 chains were identical, supporting the 
hypothesis of allelomorphism rather than gene duplica- 
tion. The absence of a significant amount of proCPBz 
in our analyzed human pancreatic juices is consistent 
with previous observations by Scheele et al. [13] and 
emphasizes the genetic differences between individuals. 
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